Research Compliance
-
Primer on Nanotechnology
May 7, 2012The Congressional Research Service has released a report entitled, “Nanotechnology: A Policy Primer“. Detailed within are current areas of nanotechnology product research and development (with examples from private and public research) and funding for these programs. The funding levels by fiscal year are available in table format, showing an increasing trend of funding. Public attitudes, broken down [...]
read more >> -
FDA approves treatment for plague without clinical trial data
April 30, 2012The FDA has approved Levaquin (levofloxacin)(Johnson & Johnson’s) for the treatment of pneumonic plague (caused by Yersinia pestis). A member of the fluoroquinolone family of drugs, it is currently approved for treatment of numerous infections, including post-inhalation Anthrax exposure. The approval was not based on human efficacy trials, however, but was approved under the agency’s Animal Efficacy [...]
read more >> -
The Forest Service’s 83 Experimental Forests and Ranges
April 30, 2012The Forest Service (USDA) operates 83 Experimental Forests and Ranges (who knew?) where intensive scientific study is undertaken to map diverse ecological sites. Among the many goals of their work, the Forest Service aims to 1. Develop of systems for managing and restoring forests, rangelands, and watersheds; 2. investigate the workings of forest and stream [...]
read more >> -
USDA Inspection Guide
April 30, 2012From APHIIS: Effective April 6, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) removed from its Web site all previous versions of the inspection guides used by the agency’s Animal Care program. APHIS replaced these versions with a consolidated Animal Care Inspection Guide to reduceconfusion and streamline information for our [...]
read more >> -
Presidential Commission Seeking Public Comments on Genome Sequence Data
April 27, 2012The availability of large-scale human genomic data sets raises questions regarding their proper collection, use and governance. The Presidential Commission for the Study of Bioethical Issues is currently focusing on these issues and is seeking input from medical professionals , scientists, ethicists, patient groups and the general public. Specific areas of interest to the Commission include: Privacy implications [...]
read more >>